Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies (Q24810552)
scientific article
Language:
(P31) (Q13442814)
(P304) R436-43
(P407) (Q1860)
(P433) 4
(P478) 7
(P577) Friday, April 8, 2005
(P921) (Q181600)
(Q12859063)
(P1433) (Q2208481)
(P1476) "Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies" (language: en)
(P2093) Francisco J Esteva
Carol D Cheli
Herbert Fritsche
Monica Fornier
Dennis Slamon
Robert P Thiel
Diana Luftner
Farooq Ghani
(P2860) (Q27824766)
(Q27860904)
(Q27860693)
(Q29547699)
(Q29617440)
(Q34276302)
(Q40618669)
(Q34184177)
(Q32033982)
(Q38463502)
(Q40630247)
(Q41098509)
(Q41036492)
(Q48369441)
(Q44969545)
(Q43918766)
(Q44438549)
(Q43937165)
(Q47969106)
(Q44529239)
(Q45123315)
(Q74360962)
(Q73308218)
(Q73984464)
(Q74509215)
(Q71059676)
other details